Remifentanil Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9391

10 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 0143-9391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Remifentanil Hydrochloride 1)

Image (Remifentanil Hydrochloride 1)
Chemical structure of remifentanil hydrochloride, showing its molecular framework including ester, amide, and phenyl groups.*
FDA Label Image

Image (Remifentanil Hydrochloride 2)

Image (Remifentanil Hydrochloride 2)
A line graph comparing minute ventilation (% of baseline) over time (minutes) for Remifentanil Hydrochloride injection (n=11) and Alfentanil (n=10). The graph shows measurements before, during, and after infusion, illustrating respiratory depression levels and recovery profiles for both drugs.*
FDA Label Image

Image (Remifentanil Hydrochloride 3)

Image (Remifentanil Hydrochloride 3)
A line graph comparing mean concentration (ng/mL) with time (minutes) for Alfentanil and Remifentanil Hydrochloride intravenous injections. The y-axis shows mean concentration on a logarithmic scale from 0.1 to 100 ng/mL, and the x-axis shows time from 0 to 480 minutes. The graph includes error bars depicting standard deviation for both drugs during the study.*
FDA Label Image

1 mg Vial (Remifentanil Hydrochloride 4)

1 mg Vial (Remifentanil Hydrochloride 4)
Label for Remifentanil Hydrochloride Injection 1 mg single dose vial. The lyophilized powder is for intravenous use only. The label includes the NDC 0143-9391-01, indicates the product is sterile and must be reconstituted and diluted before use, and is distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

2mg Vial (Remifentanil Hydrochloride 5)

2mg Vial (Remifentanil Hydrochloride 5)
Label for Remifentanil Hydrochloride for Injection, 2 mg strength, single dose vial for intravenous use only. The label indicates it is Rx only and must be reconstituted and diluted before use. Distributed by Hikma Pharmaceuticals USA Inc. The label includes NDC 0143-9392-01 and instructions to discard unused portion.*
FDA Label Image

5mg Vial (Remifentanil Hydrochloride 6)

5mg Vial (Remifentanil Hydrochloride 6)
Label for Remifentanil Hydrochloride Injection 5 mg single-dose vial. The label indicates the product is for intravenous use only, must be reconstituted and diluted before use, and is distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ.*
FDA Label Image

1 mg Carton (Remifentanil Hydrochloride 7)

1 mg Carton (Remifentanil Hydrochloride 7)
Packaging label for Remifentanil Hydrochloride Injection 1 mg by Hikma Pharmaceuticals USA Inc. The label indicates it is a lyophilized powder for intravenous use only, provided in single-dose vials, with 10 vials of 1 mg per package. It includes storage instructions and dosage equivalency to 1 mg of remifentanil.*
FDA Label Image

2 mg Carton (Remifentanil Hydrochloride 8)

2 mg Carton (Remifentanil Hydrochloride 8)
Packaging label for Remifentanil Hydrochloride Injection 2 mg, lyophilized powder for solution, intended for intravenous use. The label indicates a single dose vial with 2 mg remifentanil equivalent, distributed by Hikma Pharmaceuticals USA Inc. The label includes dosing information and administration instructions, emphasizing use for intravenous injection only.*
FDA Label Image

5 mg Carton (Remifentanil Hydrochloride 9)

5 mg Carton (Remifentanil Hydrochloride 9)
Remifentanil Hydrochloride for Injection 5 mg lyophilized powder for solution, equivalent to 5 mg of remifentanil, for intravenous use only. The label shows a single dose vial with the product strength and usage instructions. It is labeled by Hikma Pharmaceuticals USA Inc., with warnings about storage and discarding unused portions. The package includes instructions and barcodes consistent with FDA requirements.*
FDA Label Image

Serialization Image (Remifentanil Hydrochloride 10)

Serialization Image (Remifentanil Hydrochloride 10)
A product identifier label for remifentanil hydrochloride injection powder, lyophilized, for solution. The label includes placeholder text for GTIN, lot number, expiration date, and serial number, along with a data matrix 2D barcode on the right side. The label is designed for human prescription drug packaging by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.